A simple, efficient and environmentally benign synthetic protocol for the synthesis of spirooxindoles using choline chloride-oxalic acid eutectic mixture as catalyst/solvent system

Combinatorial Chemistry and High Throughput Screening

Volumn 17, Issue 9, 2014, Pages 763-769

  Khandelwal, Sarita ^a   Rajawat, Anshu ^a   Tailor, Yogesh Kumar ^a   Kumar, Mahendra ^a  

^a UNIVERSITY OF RAJASTHAN   (India)

Author keywords

Deep eutectic solvent (DES); Diversity oriented synthesis; HBD (hydrogen bond donor); Medicinally privileged heterocycles; Spirooxindoles

Indexed keywords

ADIPIC ACID; CARBONYL DERIVATIVE; CHOLINE; DEEP EUTECTIC SOLVENT; INDOLE DERIVATIVE; ISATIN DERIVATIVE; MALONIC ACID; OXALIC ACID; PYRIMIDINE DERIVATIVE; SOLVENT; SUCCINIC ACID; UNCLASSIFIED DRUG; URACIL DERIVATIVE; OXINDOLE; SPIRO COMPOUND;

ANNULATION REACTION; ARTICLE; CATALYSIS; CATALYST; CHEMICAL REACTION; CHEMICAL STRUCTURE; FILTRATION; MELTING POINT; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION ANALYSIS; REACTION TIME; SYNTHESIS; THIN LAYER CHROMATOGRAPHY; CHEMISTRY;

CATALYSIS; CHOLINE; INDOLES; MOLECULAR STRUCTURE; OXALIC ACID; SOLVENTS; SPIRO COMPOUNDS;

EID: 84928656582     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/1386207317666141016125218     Document Type: Article

References (53)

1. Alvim, H. G. O.; Bataglion, G. A.; Ramos, L. M.; De Oliveira, A. L.; De Oliveira, H. C. B.; Eberlin, M. N.; De Macedo, J. L.; Da Silva, W. A.; Neto, B. A. D. Task-specific ionic liquid incorporating anionic heteropolyacid-catalyzed Hantzsch and Mannich multicomponent reactions. Ionic liquid effect probed by ESIMS (/MS), Tetrahedron, 2014, 70, 3306-3313.
2. Hallet, J. P.; Welton, T. Room-Temperature Ionic Liquids: Solvents for Synthesis and Catalysis. 2. Chem. Rev., 2011, 111, 3508-3576.
3. (a) Romero, A.; Santos, A.; Tojo, J.; Rodrýguez, A. Toxicity and biodegradability of imidazolium ionic liquids. J. Hazard. Mater., 2008, 151, 268-273;
4. (b) Plechkova, N. V.; Seddon, K. R. Chem. Soc. Rev. 2008, 37, 123;
5. (c) Ramesh, S.; Shanti, R. Exerted influence of deep eutectic solvent concentration in the room temperature ionic conductivity and thermal behavior of corn starch based polymer electrolytes. Journal of Molecular Liquids, 2012, 166, 40-43.
6. Santos, J.; Lopes, J.; Coutinho, J.; Esperança, J.; Gomes, L.; Marrucho, I.; Rebelo, L. Ionic Liquids: First Direct Determination of their Cohesive Energy. J. Am. Chem. Soc., 2007, 129, 284.
7. (a) Pawar, P. M.; Jarag, K. J.; Shankarling, G. S. Environmentally benign and energy efficient methodology for condensation: an interesting facet to the classical Perkin reaction. Green Chem. 2011, 13, 2130-2134;
8. (b) Azizi, N.; Dezfooli, S.; Khajeh, M.; Hashemi, M. M. Efficient deep eutectic solvents catalyzed synthesis of pyran and benzopyran derivatives. Journal of Molecular Liquids, 2013, 186, 76-80.
9. (a) Abbott, A. P.; Frisch, G.; Hartley, J.; Ryder, K. S. Processing of metals and metal oxides using ionic liquids. Green Chem., 2011, 13, 471-481;
10. (b) Abbott, A. P.; Harris, R. C.; Ryder, K. S.; Agostino, C. D.; Gladden, L. F.; Mantle, M. D. Glycerol eutectic as sustainable solvent systems. Green Chem., 2011, 13, 82-90;
11. (c) Maugeri, Z.; Domýnguez De Marýa, P. Novel choline-chloride-based deepeutecticsolvents with renewablehydrogen bond donors: levulinic acid and sugar-based polyols. RSC Adv., 2012, 2, 421-425;
12. (d) Handy, S.; Lavender, K. Organic synthesis in deep eutectic solvents: Paal-Knorr reactions. Tetrahedron Lett., 2013, 54, 4377-4379.
13. (a) Kammasud, N.; Boonyarat, C.; Sanphanya, K. 5-Substituted pyrido[2, 3-d]pyrimidine, an inhibitor against three receptor tyrosine kinases. Bioorg. Med. Chem. Lett., 2009, 19, 745-750;
14. (b) Huron, D. R.; Gorre, M. E.; Kraker, A. J.; Sawyers, C. L.; Rosen, N.; Moasser, M. M. A novel pyridopyrimidine inhibitor of abl kinase is a picomolar inhibitor of Bcr-abl-driven K562 cells and is effective against STI571-resistant Bcr-abl mutants. Clin. Cancer Res., 2003, 9, 1267-1273;
15. (c) Gangjee, A.; Vasudevan, A.; Queener, S. F.; Kisliuk, R. L. 2, 4-diamino-5-deaza-6-substituted pyrido[2, 3-d]pyrimidine antifolates as potent and selective nonclassical inhibitors of dihydrofolate reductases. J. Med. Chem., 1996, 39, 1438-1446;
16. (d) Tanifum, E. A.; Kots, A. Y.; Choi, B.-K.; Murad, F.; Gilbertson, S. R. Novel pyridopyrimidine derivatives as inhibitors of stable toxin a (STa) induced cGMP synthesis. Biorg. Med. Chem. Lett., 2009, 19, 3067-3071;
17. (e) Malaga, K.; Duggan, H.; Menear, K. The discovery and optimisation of pyrido[2, 3-d]pyrimidine-2, 4-diamines as potent and selective inhibitors of mTOR kinase. Bioorg. Med. Chem. Lett., 2009, 19, 5950-5953;
18. (f) VanderWel, S. N.; Harvey, P. J.; McNamara, D. J.; Repine, J. T.; Keller, P. R.; Quin, J.,; Booth, R. J.; Elliott, W. L.; Dobrusin, E. M.; Fry, D. W.; Toogood, P. L. Pyrido[2, 3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4. J. Med. Chem., 2005, 48, 2371-2387;
19. (g) Moreno, E.; Plano, D.; Lamberto, I.; Font, M.; Enico, I.; Palop, J. A.; Martin, C. S. Sulfur and selenium derivatives of quinazoline and pyrido[2, 3-d]pyrimidine: Synthesis and study of their potential cytotoxic activity in vitro. Eur. J. Med. Chem., 2012, 47, 283-298;
20. (h) Wang, X. S.; Zeng, Z. S.; Shi, D. Q.; Wei, X. Y.; Zong, Z. M. KF-Alumina Catalyzed One-Pot Synthesis of Pyrido[2, 3-d]Pyrimidine Derivatives. Synth. Commun., 2004, 34, 4331-4337;
21. (i) Narayana, B. L.; Rao, A. R. R.; Rao, P. S. Synthesis of new 2-substituted pyrido[2, 3-d]pyrimidin-4 (1H)-ones and their antibacterial activity. Eur. J. Med. Chem., 2009, 44, 1369-1376;
22. (j) El-Gazzar, A. B. A.; Hafez, H. N. Synthesis of 4-substituted pyrido[2, 3-d]pyrimidin-4 (1H)-one as analgesic and antiinflammatory agents. Bioorg. Med. Chem. Lett., 2009, 19, 3392-3397;
23. (k) Cordeu, L.; Cubedo, E.; Bandres, E.; Rebollo, A.; Saenz, X.; Chozes, H. M.; Dominquez, V.; Echeverria, M.; Mendivil, B.; Sanmartin, C.; Palop, J. A.; Font, M.; Garcia-Foncillas, J. Biological profile of new apoptotic agents based on 2, 4-pyrido[2, 3-d]pyrimidine derivatives. Bioorg. Med. Chem., 2007, 15, 1659-1669;
24. (l) Ahluwalia, V. K.; Bhatla, R.; Khurana, A.; Kumar, R. Indian J. Chem. Sect. B, 1990, 29, 1141;
25. (m) Kots, A. Y.; Choi, B.-K.; Estrella-Jimenez, M. E.; Warren, C. A.; Gilbertson, S. R.; Guerrant, R. L.; Murad, F. Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea. Proc. Natl. Acad. Sci., 2008, 105, 8440-8445.
26. Rizkalla, B. H.; Broom, A. D. J. Pyrido (2, 3-d) pyrimidines. 3. Synthesis of some 8-(-D-ribofuranosyl) pyrido (2, 3-d) pyrimidines structurally related to the antibiotic sangivamycin. J. Org. Chem., 1972, 37, 3980-3985.
27. (a) Santos, M. M. M. Recent advances in the synthesis of biologically active spirooxindoles. Tetrahedron, 2014 (In Press, Accepted Manuscript, Available online);
28. (b) Zheng, Y.; Tice, C. M.; Singh, S. B. The use of spirocyclic scaffolds in drug discovery. Bioorganic & Medicinal Chemistry Letters, 2014, 24, 3673-3682;
29. (c) Singh, G. S.; Desta, Z. Y. Isatins As Privileged Molecules in Design and Synthesis of Spiro-Fused Cyclic Frameworks. Chem. Rev., 2012, 112, 6104-6155.
30. (a) Girgis, A. S.; Stawinski, J.; Ismail, N. S.; Farag, H. Synthesis and QSAR study of novel cytotoxic spiro[3H-indole-3, 2" (1"H) - pyrrolo[3, 4-c]pyrrole]-2, 3", 5" (1H, 2"aH, 4"H)-triones. Eur. J. Med. Chem., 2012, 47, 312-322;
31. (b) Arun, Y.; Bhaskar, G.; Balachandran, C.; Ignacimuthu, S.; Perumal, P. T. Facile one-pot synthesis of novel dispirooxindole-pyrrolidine derivatives and their antimicrobial and anticancer activity against A549 human lung adenocarcinoma cancer cell line. Bioorganic & Medicinal Chemistry Letters, 2013, 23, 1839-1845;
32. (c) Efremov, I. V.; Vajdos, F. F.; Borzilleri, K. A.; Capetta, S.; Chen, H.; Dorff, P. H.; Dutra, J. K.; Goldstein, S. W.; Mansour, M.; McColl, A.; Noell, S.; Oborski, C. E.; O'Connell, T. N.; O'Sullivan, T. J.; Pandit, J.; Wang, H.; Wei, B.; Withka, J. M. Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of α-Secretase (BACE1) through Fragment-Based Drug Design. J. Med. Chem., 2012, 55, 9069-9088;
33. (e) Xia, M.; Ma, R.-Z. Recent Progress on Routes to Spirooxindole Systems Derived from Isatin. Journal of Heterocyclic Chemistry, 2014, 51, 539-554.
34. (a) Jossang, A.; Josslang, P.; Hadi, H. A.; Sevenet, T.; Bodo, B. Horsfiline, an oxindole alkaloid from Horsfieldia superb. J. Org. Chem. 1991, 56, 6527-6530;
35. (b) Elderfield, R. C.; Gilman, R. E. Alkaloids of Alstonia Muelleriana. Phytochemistry, 1972, 11, 339-343;
36. (c) Tang, W.; Eisenbrand, G. Chinese Drugs of Plant Origin, Chemistry, Pharmacology and Use in Traditional and Modern Medicine, Springer-Verlag, Berlin, 1992, pp. 997-1002.
37. (d) Garcia Prado, E.; Garcia Gimenez, M. D.; De La Puerta Vazquez, R.; Espartero Sanchez, J. L.; Saenz Rodriguez, M. T. Antiproliferative effects of mitraphylline, a pentacyclic oxindole alkaloid of Uncaria tomentosa on human glioma and neuroblastoma cell lines. Phytomedicine, 2007, 14, 280-284;
38. (e) Colegate, S. M.; Anderton, N.; Edgar, J.; Bourke, C. A.; Oram, R. N. Suspected blue canary grass (Phalaris coerulescens) poisoning of horses. Aust. Vet. J. 1999, 77, 537-538;
39. (f) Sakai, S.; Aimi, N.; Yamaguchi, K.; Ohhira, H.; Hori, K.; Haginiwa, J. Gardneria alkaloids-IX structures of chitosenine and three other minor bases: From Gardneria multiflora makino. Tetrahedron Lett., 1975, 16, 715-718;
40. (i) Cui, C. B.; Kakeya, H.; Osada, H. Spirotryprostatin B, a novel mammalian cell cycle inhibitor produced by Aspergillus fumigates. J. Antibiot., 1996, 49, 832-835;
41. (j) Sebahhar, P. R.; Williams, R. M. The Asymmetric Total Synthesis of (+) - and (.) - Spirotryprostatin B. J. Am. Chem. Soc., 2000, 122, 5666-5667.
42. (a) Arya, A. K.; Kumar, M. Base catalyzed multicomponent synthesis of spiroheterocycles with fused heterosystems. Mol. Divers., 2011, 15, 781-789;
43. (b) Arya, A. K.; Gupta, S. K.; Kumar, M. A domino protocol for the efficient synthesis of structurally diverse benzothiazolylquinoline-2, 5-diones and their spiro analogues. Tetrahedron Lett., 2012, 53, 6035-6038;
44. (c) Kumar, M.; Sharma, K.; Arya, A. K. Use of SO3H-functionalized halogenfree ionic liquid ([MIM (CH2) 4SO3H] [HSO4]) as efficient promoter for the synthesis of structurally diverse spiroheterocycles. Tetrahedron Lett., 2012, 53, 4604-4608;
45. (d) Arya, A. K.; Kumar, M. An efficient green chemical approach for the synthesis of structurally diverse spiroheterocycles with fused heterosystems. Green Chem., 2011, 13, 1332-1338;
46. (e) Khandelwal, S.; Rajawat, A.; Kumar, M. An Efficient and environmentally benign four-component domino protocol for synthesis of spirooxindoles spiroannulated with fused heterosystems of privileged heterocycles. Current Bioactive Compounds, 2013, 09, 203-210;
47. (f) Kumar, M.; Sharma, K., Sharma, D. K.; Arya, A. K. An efficient, ionic liquid mediated onepot, three component sequential synthesis of 3-benzothiazolyl-2-styrylquinazolin-4 (3H)-ones. Tetrahedron Lett., 2013, 54, 878-882;
48. (g) Rajawat, A.; Khandelwal, S.; Kumar, M. Deep eutectic solvent promoted efficient and environmentally benign four-component domino protocol for synthesis of spirooxindoles. RSC Adv., 2014, 4, 5105-5112.
49. (a) Kumar, M.; Sharma, K.; Samarth, R. M.; Kumar, A. Synthesis and antioxidant activity of quinolinobenzothiazinones. Eur. J. Med. Chem., 2010, 45, 4467-4472;
50. (b) Gupta, R. R.; Kumar, M. "Synthesis, Reactions and Properties of Phenothiazines" in Phenothiazines and 1, 4-Benzothiazines, Chemical and Biomedical Aspect. Elsevier: Amsterdam, 1998, 1-161.
51. (a) Rathore, B. S.; Kumar, M. Synthesis of 7-chloro-5-trifluoromethyl/7-fluoro/7-trifluoromethyl-4H-1, 4-benzothiazines as antimicrobial agents. Bioorg. Med. Chem., 2006, 14, 5678-5682;
52. (b) Rathore, B. S.; Gupta, V.; Gupta, R. R.; Kumar, M. Synthesis of 7-chloro-9-trifluoromethyl-/7-fluorophenothiazines. Heteroatom Chem., 2007, 18, 81-86;
53. (c) Khandelwal, S.; Rajawat, A.; Kumar, M. L-Proline catalyzed synthesis of structurally diverse 1, 4-dihydropyridines fused with medicinally privileged heterocyclic systems. Current Organocatalysis, 2014, 1. 51-58.